Elucidation of Structure-activity Relationship of 2-Quinolone Derivatives and Exploration of Their Antitumor Potential Through Bax-induced Apoptotic Pathway

Nitesh Kumar, Vasanth P. Raj, B. S. Jayshree, Sidhartha S. Kar, Arvind Anandam, Seeja Thomas, Prateek Jain, Amita Rai, C. M. Rao

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

3-Aryl-2-quinolone derivates were extensively investigated for their inhibition of farnesyl transferase. Taking this as a cue, we studied the other possible mechanism of antitumor activity of 2-quinolone derivates. A series of new 2-quinolone derivatives have been synthesized and screened for their cytotoxicity by trypan blue assay on Ehrlich ascites carcinoma cells and MTT assay on MCF-7 cells. Compound 1a (nJST) was found to be more effective in both studies with the lowest CTC 50 value among all nine synthesized compounds. This compound was further screened on four different cell lines, viz. human breast adenocarcinoma (MCF-7, MDA-MB-231), colon cancer (HCT-15), murine melanoma (B16F10) cell lines for 24 and 48h. The CTC 50 value of the compound was found to be <10μm. Compound 1a induced DNA damage which was revealed by DNA fragmentation studies and further confirmed by nuclear staining. The compound also showed significant elevation in Bax and reduction Bcl-2 gene expression levels. Acute toxicity study in mice indicated that the compound is safe till 2000mg/kg. Two different doses 50 and 100mg/kg were selected and studied in Ehrlich ascites carcinoma model of cancer and have shown significant improvement in survival time and hematological parameters.

Original languageEnglish
Pages (from-to)291-299
Number of pages9
JournalChemical Biology and Drug Design
Volume80
Issue number2
DOIs
Publication statusPublished - 08-2012

Fingerprint

Structure-Activity Relationship
Cells
Derivatives
Ascites
Assays
Carcinoma
bcl-2 Genes
Cell Line
Trypan Blue
DNA
MCF-7 Cells
DNA Fragmentation
Cytotoxicity
Transferases
Gene expression
Colonic Neoplasms
DNA Damage
Cues
Toxicity
Melanoma

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine

Cite this

@article{d684af353f104b028bc899bbb0752cf6,
title = "Elucidation of Structure-activity Relationship of 2-Quinolone Derivatives and Exploration of Their Antitumor Potential Through Bax-induced Apoptotic Pathway",
abstract = "3-Aryl-2-quinolone derivates were extensively investigated for their inhibition of farnesyl transferase. Taking this as a cue, we studied the other possible mechanism of antitumor activity of 2-quinolone derivates. A series of new 2-quinolone derivatives have been synthesized and screened for their cytotoxicity by trypan blue assay on Ehrlich ascites carcinoma cells and MTT assay on MCF-7 cells. Compound 1a (nJST) was found to be more effective in both studies with the lowest CTC 50 value among all nine synthesized compounds. This compound was further screened on four different cell lines, viz. human breast adenocarcinoma (MCF-7, MDA-MB-231), colon cancer (HCT-15), murine melanoma (B16F10) cell lines for 24 and 48h. The CTC 50 value of the compound was found to be <10μm. Compound 1a induced DNA damage which was revealed by DNA fragmentation studies and further confirmed by nuclear staining. The compound also showed significant elevation in Bax and reduction Bcl-2 gene expression levels. Acute toxicity study in mice indicated that the compound is safe till 2000mg/kg. Two different doses 50 and 100mg/kg were selected and studied in Ehrlich ascites carcinoma model of cancer and have shown significant improvement in survival time and hematological parameters.",
author = "Nitesh Kumar and Raj, {Vasanth P.} and Jayshree, {B. S.} and Kar, {Sidhartha S.} and Arvind Anandam and Seeja Thomas and Prateek Jain and Amita Rai and Rao, {C. M.}",
year = "2012",
month = "8",
doi = "10.1111/j.1747-0285.2012.01402.x",
language = "English",
volume = "80",
pages = "291--299",
journal = "Chemical Biology and Drug Design",
issn = "1747-0277",
publisher = "Blackwell",
number = "2",

}

Elucidation of Structure-activity Relationship of 2-Quinolone Derivatives and Exploration of Their Antitumor Potential Through Bax-induced Apoptotic Pathway. / Kumar, Nitesh; Raj, Vasanth P.; Jayshree, B. S.; Kar, Sidhartha S.; Anandam, Arvind; Thomas, Seeja; Jain, Prateek; Rai, Amita; Rao, C. M.

In: Chemical Biology and Drug Design, Vol. 80, No. 2, 08.2012, p. 291-299.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Elucidation of Structure-activity Relationship of 2-Quinolone Derivatives and Exploration of Their Antitumor Potential Through Bax-induced Apoptotic Pathway

AU - Kumar, Nitesh

AU - Raj, Vasanth P.

AU - Jayshree, B. S.

AU - Kar, Sidhartha S.

AU - Anandam, Arvind

AU - Thomas, Seeja

AU - Jain, Prateek

AU - Rai, Amita

AU - Rao, C. M.

PY - 2012/8

Y1 - 2012/8

N2 - 3-Aryl-2-quinolone derivates were extensively investigated for their inhibition of farnesyl transferase. Taking this as a cue, we studied the other possible mechanism of antitumor activity of 2-quinolone derivates. A series of new 2-quinolone derivatives have been synthesized and screened for their cytotoxicity by trypan blue assay on Ehrlich ascites carcinoma cells and MTT assay on MCF-7 cells. Compound 1a (nJST) was found to be more effective in both studies with the lowest CTC 50 value among all nine synthesized compounds. This compound was further screened on four different cell lines, viz. human breast adenocarcinoma (MCF-7, MDA-MB-231), colon cancer (HCT-15), murine melanoma (B16F10) cell lines for 24 and 48h. The CTC 50 value of the compound was found to be <10μm. Compound 1a induced DNA damage which was revealed by DNA fragmentation studies and further confirmed by nuclear staining. The compound also showed significant elevation in Bax and reduction Bcl-2 gene expression levels. Acute toxicity study in mice indicated that the compound is safe till 2000mg/kg. Two different doses 50 and 100mg/kg were selected and studied in Ehrlich ascites carcinoma model of cancer and have shown significant improvement in survival time and hematological parameters.

AB - 3-Aryl-2-quinolone derivates were extensively investigated for their inhibition of farnesyl transferase. Taking this as a cue, we studied the other possible mechanism of antitumor activity of 2-quinolone derivates. A series of new 2-quinolone derivatives have been synthesized and screened for their cytotoxicity by trypan blue assay on Ehrlich ascites carcinoma cells and MTT assay on MCF-7 cells. Compound 1a (nJST) was found to be more effective in both studies with the lowest CTC 50 value among all nine synthesized compounds. This compound was further screened on four different cell lines, viz. human breast adenocarcinoma (MCF-7, MDA-MB-231), colon cancer (HCT-15), murine melanoma (B16F10) cell lines for 24 and 48h. The CTC 50 value of the compound was found to be <10μm. Compound 1a induced DNA damage which was revealed by DNA fragmentation studies and further confirmed by nuclear staining. The compound also showed significant elevation in Bax and reduction Bcl-2 gene expression levels. Acute toxicity study in mice indicated that the compound is safe till 2000mg/kg. Two different doses 50 and 100mg/kg were selected and studied in Ehrlich ascites carcinoma model of cancer and have shown significant improvement in survival time and hematological parameters.

UR - http://www.scopus.com/inward/record.url?scp=84864023497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864023497&partnerID=8YFLogxK

U2 - 10.1111/j.1747-0285.2012.01402.x

DO - 10.1111/j.1747-0285.2012.01402.x

M3 - Article

C2 - 22553933

AN - SCOPUS:84864023497

VL - 80

SP - 291

EP - 299

JO - Chemical Biology and Drug Design

JF - Chemical Biology and Drug Design

SN - 1747-0277

IS - 2

ER -